《新股消息》诺辉健康(06606.HK)明日起招股 入场费约13,464.33元
诺辉健康(06606.HK)公布招股详情,计划发行7,659.8万股,当中约90%即约6,893.8万股为国际配售,约10%即约766万股为本地公开发售,另设15%超额配股权。招股价介乎每股22.7至26.66元,集资最多约20.42亿元。未计手续费,每手500股入场费约13,464.33元。该公司将於明日(5日)起至下周三(10日)招股,预期2月18日挂牌上市,联席保荐人为高盛及瑞银。
是次招股引入16名基石投资者,包括景顺、清池资本、博裕、GIC、加皇环球资产管理、Columbia Funds、骏利亨德森资产管理、Rock Springs Capital Master Fund LP、Worldwide Healthcare Trust PLC、礼来亚洲旗下LAV Amber Limited、Cormorant Global、HBC Asia Healthcare Opportunities VII LLC、Octagon Investments Master Fund LP、Sage Partners Master Fund、南方基金管理及E Fund,合共认购1.24亿美元等值股份。
以招股价中位数每股24.68元计,所得款项净额约为17.54亿元,当中约40%用於为产品「常卫清」的商业化及进一步开发提供资金;约30%用於为正在进行及计划进行的早期阶段管线产品研发提供资金;约15%将用於潜在收购或外部引进癌症筛查领域的候选产品;约5%用於为产品「噗噗管」的持续销售及营销提供资金;以及约10%为一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.